Moderna and Merck Break Cancer Vaccine Barrier After Century-Long Struggle

Moderna and Merck have achieved a major breakthrough in cancer vaccine development, marking the first success in over a century of attempts.

The news came as a surprise to Stephane Bancel, CEO of Moderna, who received a call while celebrating his friend's birthday at a Lebanese restaurant on August 13th.

According to Reuters, the two companies have been working together to develop an mRNA-based cancer vaccine. While details are scarce, experts believe this breakthrough could potentially revolutionize cancer treatment and save countless lives.